On Tuesday, results of the new study boosted Dendreon stock by $9.69, closing at $16.99 ... The cells are mixed with a protein found on most prostate cancer cells to help activate the immune system. The resulting "vaccine" is given back …
Shares in Dendreon Corp have gone through the roof after the US firm presented highly positive late-stage data on its investigational prostate cancer vaccine Provenge. The company says that its Phase III IMPACT study of Provenge …
Valeant recently closed the sale of Dendreon Pharmaceuticals and used net proceeds to ... Valeant shares rose 59 cents to close at $19.74 on the Toronto Stock Exchange. But the stock remains a shadow of its former self when it traded for …
CBC4mon
Prostate cancer drug developer Dendreon is seeking Chapter ... to resign for personal reasons. Shares of Dendreon shed most of their value Monday before markets opened, sinking 67 cents to 27 cents. The stock had slipped below $1 …
DNDN is poised to plunge 69.2% -- deeper into penny-stock territory -- after the firm filed for Chapter 11 bankruptcy protection. Dendreon Corporation said it's reached deals with some bond holders regarding a financial restructuring -- …
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free. Here are highlights …
All public companies need to avoid the wrath of securities regulators by disclosing important developments that could affect their stock prices ... to get caught in this conflict is Seattle's Dendreon, which revealed Tuesday that the SEC is …
Investors can view all of the daily updates for free by visiting: http://stockpreacher.com/StockTalk Today's Trade Alerts include: Broadwind Energy, Inc. , BHP Billiton Ltd. , Citigroup Inc. , Candela Corporation , Dendreon Corporation , …
That erased a dramatic build-up in the stock price since March, when an FDA panel recommended approval. Here’s the Associated Press news story from that day, http://biz.yahoo.com/ap/070509/dendreon_mover.html?.v=1. Since then, …
Without much ado here are some thoughts to ponder over the weekend: Tech Data Corp. (TECD): Yesterday the stock completed a sell countdown and on a traditional chart it did so on a huge spike in volume. The stock then reversed. …